191 related articles for article (PubMed ID: 12902521)
21. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
[TBL] [Abstract][Full Text] [Related]
22. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.
Balabanian K; Couderc J; Bouchet-Delbos L; Amara A; Berrebi D; Foussat A; Baleux F; Portier A; Durand-Gasselin I; Coffman RL; Galanaud P; Peuchmaur M; Emilie D
J Immunol; 2003 Mar; 170(6):3392-400. PubMed ID: 12626600
[TBL] [Abstract][Full Text] [Related]
23. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
24. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
25. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice.
Yang JQ; Saxena V; Xu H; Van Kaer L; Wang CR; Singh RR
J Immunol; 2003 Oct; 171(8):4439-46. PubMed ID: 14530371
[TBL] [Abstract][Full Text] [Related]
26. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.
Zeng D; Lee MK; Tung J; Brendolan A; Strober S
J Immunol; 2000 May; 164(10):5000-4. PubMed ID: 10799851
[TBL] [Abstract][Full Text] [Related]
28. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
29. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
30. Immunoregulatory role of Jalpha281 T cells in aged mice developing lupus-like nephritis.
Sireci G; Russo D; Dieli F; Porcelli SA; Taniguchi M; La Manna MP; Di Liberto D; Scarpa F; Salerno A
Eur J Immunol; 2007 Feb; 37(2):425-33. PubMed ID: 17273990
[TBL] [Abstract][Full Text] [Related]
31. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
32. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium.
Berntman E; Rolf J; Johansson C; Anderson P; Cardell SL
Eur J Immunol; 2005 Jul; 35(7):2100-9. PubMed ID: 15940666
[TBL] [Abstract][Full Text] [Related]
33. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
Gumperz JE; Miyake S; Yamamura T; Brenner MB
J Exp Med; 2002 Mar; 195(5):625-36. PubMed ID: 11877485
[TBL] [Abstract][Full Text] [Related]
34. Involvement of CD1 in peripheral deletion of T lymphocytes is independent of NK T cells.
Dao T; Exley M; Mehal WZ; Tahir SM; Snapper S; Taniguchi M; Balk SP; Crispe IN
J Immunol; 2001 Mar; 166(5):3090-7. PubMed ID: 11207260
[TBL] [Abstract][Full Text] [Related]
35. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
[TBL] [Abstract][Full Text] [Related]
36. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
Belperron AA; Dailey CM; Bockenstedt LK
J Immunol; 2005 May; 174(9):5681-6. PubMed ID: 15843569
[TBL] [Abstract][Full Text] [Related]
37. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells.
Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI
J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083
[TBL] [Abstract][Full Text] [Related]
38. Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models.
Guo Q; Zhang L; Yaron JR; Burgin M; Schutz LN; Awo EA; Lucas AR
Methods Mol Biol; 2021; 2225():241-255. PubMed ID: 33108667
[TBL] [Abstract][Full Text] [Related]
39. Disparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.
Jacinto J; Kim PJ; Singh RR
Lupus; 2012 Apr; 21(5):485-90. PubMed ID: 22065098
[TBL] [Abstract][Full Text] [Related]
40. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
